相关实验视频
Updated: Jun 1, 2025

06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
5.1K
除了破坏之外:E3无酸酶Hakai的新兴作用
Juan-José Escuder-Rodríguez1, Andrea Rodríguez-Alonso1, Lía Jove1
1Epithelial Plasticity and Metastasis Group, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), Xubias de Arriba 84, 15006, A Coruña, Spain.
Cellular & molecular biology letters
|January 20, 2025
概括
哈凯蛋白质是癌症的关键参与者,在RNA修饰中具有新发现的作用,超出其已知的蛋白质降解功能. 这一发现突显了其在癌症诊断和精准医学方面的潜力.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 哈卡伊 (CBLL1基因) 被称为针对E-cadherin的E3泛素化酶,促进表皮细胞到介质酶的过渡.
- 最近的研究揭示了Hakai在N6-甲基氨酸 (m6A) RNA编写复合体中的非正规作用,独立于其结合酶活性.
研究的目的:
- 审查Hakai在RNA甲基化中的非正规功能.
- 讨论Hakai作为癌症生物标志物的新兴作用及其预后价值.
- 探索针对Hakai在精准医学中的治疗潜力.
主要方法:
- 对最近关于Hakai的功能研究的文献评论.
- 对Hakai参与RNA修饰途径的分析.
- 讨论在Hakai向治疗中的临床前和临床发展.
主要成果:
- 哈卡伊的非正典活动通过m6A.A.显著影响mRNA修饰.
- 哈卡伊证明了作为癌症诊断和预后的生物标志物的潜力.
- 针对Hakai的基质结合域的小分子抑制剂的开发显示出治疗的前景.
结论:
- 哈卡伊在蛋白质降解和RNA修饰中的双重作用将其定位为癌症进展的关键因素.
- 对Hakai的功能进行进一步的调查可能会为癌症治疗和精准医学开辟新的途径.
- 准Hakai为开发新型癌症治疗提供了一个有前途的战略.
相关概念视频
Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
The Proteasome
807
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
807
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
Intralumenal Vesicles and Multivesicular Bodies
3.4K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.4K

